Cardiomyopathy in patients treated with clozapine [2];Cardiomiopatia em paciente tratada com clozapina

Revista Brasileira de Psiquiatria

Volumn 27, Issue 2, 2005, Pages 164-

  De Boni, Raquel ^a   Gama, Clarissa Severino ^a   Lobato, Maria Inês ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; LITHIUM CARBONATE; RISPERIDONE; VALPROIC ACID;

CARDIOMYOPATHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART FAILURE; HUMAN; LETTER; MYOCARDITIS; SCHIZOPHRENIA;

EID: 22344450061     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-44462005000200020     Document Type: Letter

References (5)

1. American Psychiatrie Association. Practice guideline for the treatment of patients with schizophrenia. 2th ed. Washington DC: APA; 2004.
2. Iqbal MM, Rahman A, Husain Z, Mahmud SZ, Ryan WG, Feldman JM. Clozapine: a clinical review of adverse effects and management. Ann Clin Psychiatry. 2003;15(1):33-48.
3. Wooltorton E. Antipsychotic clozapine (Clozaril): myocarditis and cardiovascular toxicity. CMAJ. 2002;166(9):1185-6.
4. Killian JG, Kerr K, Lawrence C, Celermajer DS. Myocarditis cardiomyopathy associated with clozapine. Lancet. 1999;354(9193):1841-5.
5. Warner B, Alphs L, Schaedelin J, Koestler T. Clozapine and sudden death [letter]. Lancet. 2000;355(9206):842; author reply 843.